HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

GSK 1363089

a multikinase inhibitor that acts on Met, RON, Axl, and VEGFR; structure in first source
Also Known As:
EXEL 2880; EXEL-2880; GSK-1363089; GSK1363089; XL 880; XL-880; XL880 cpd; foretinib
Networked: 72 relevant articles (6 outcomes, 21 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Bottaro, Donald P: 6 articles (01/2021 - 01/2013)
2. Kallender, Howard: 5 articles (01/2021 - 01/2013)
3. Adams, Laurel M: 5 articles (12/2015 - 02/2012)
4. Keer, Harold: 4 articles (01/2021 - 01/2013)
5. Liu, Yuan: 4 articles (01/2021 - 03/2011)
6. Mohareb, Rafat M: 4 articles (01/2021 - 01/2018)
7. Cecchi, Fabiola: 3 articles (01/2021 - 01/2013)
8. Liu, Li: 3 articles (01/2021 - 03/2011)
9. Martin, Anne-Marie: 3 articles (01/2021 - 03/2011)
10. Rabe, Daniel C: 3 articles (01/2021 - 01/2013)

Related Diseases

1. Neoplasms (Cancer)
2. Stomach Neoplasms (Stomach Cancer)
3. Triple Negative Breast Neoplasms
4. Brain Neoplasms (Brain Tumor)
5. Neoplasm Metastasis (Metastasis)

Related Drugs and Biologics

1. entrectinib
2. c-Mer Tyrosine Kinase
3. GSK 1363089
4. Phosphotransferases (Kinase)
5. Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
6. Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
7. Biomarkers (Surrogate Marker)
8. Lapatinib (GW572016)
9. Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
10. Tyrosine (L-Tyrosine)

Related Therapies and Procedures

1. Therapeutics
2. Axotomy
3. Immunotherapy
4. Drug Therapy (Chemotherapy)